key: cord-0740756-u0yeyyhd
authors: de Miranda Costa, Magda Machado; Guedes, Ana Rubia; da Purificação Nogueira, Maria Dolores Santos; de Oliveira, Luciana Silva da Cruz; de Souza Barros, Lilian; Goncalves, Mara Rubia Santos; Carvalho, André Anderson; de Moura, Humberto Luiz Couto Amaral; Levin, Anna S.; Oliveira, Maura Salaroli
title: Nationwide surveillance system to evaluate hospital-acquired COVID-19 in Brazilian hospitals
date: 2022-02-14
journal: J Hosp Infect
DOI: 10.1016/j.jhin.2022.02.004
sha: 251f4faedca22390179fd3fd1156441dc34105f6
doc_id: 740756
cord_uid: u0yeyyhd

BACKGROUND: Although the risk of SARS-CoV-2 transmission within hospitals has been well recognized, there is a paucity of data on its occurrence. Our aim was to report the incidence of hospital-acquired (HA) COVID-19 at Brazilian hospitals. METHODS: We investigated the incidence of HA COVID-19 in Brazilian hospitals using data from a national surveillance system, from August 2020 through September 2021. Definitions of HA COVID-19 were: I-symptom onset >14 after hospital admission plus a positive SARS-CoV-2 RNA or antigen test; II-symptom onset on days 8-14 after admission, plus a positive SARS-CoV-2 RNA or antigen test positive, plus documented high-risk exposure. We performed descriptive analyses and reported HA COVID-19 rates using pooled mean and percentile distribution. RESULTS: 48,634 cases of HA COVID-19 were reported from 1,428 hospitals. Incidence ranged from 0.16/1000 patients-days at neonatal ICUs until 5.8/1000 patients-days at adults ICUs. The highest incidence of HA COVID-19 was during the months March to July 2021, similar of what was observed for community-acquired COVID-19. CONCLUSIONS: This report provides a national view of the burden of HA COVID-19. The highest incidence of HA COVID-19 similar of what was observed of community-acquired. We believe that this reflects the difficulty of implementing preventive measures. Further studies evaluating risk factors for the hospital transmission of SARS-Cov-2 should clarify strategies to minimize the risk of HA COVID-19 and may be applicable to other respiratory diseases. Furthermore, the implementation of a national system to evaluate HA COVID-19 has the potential to turn this problem visible and lead to interventions in each hospital.

The first report of coronavirus disease (COVID-19) cases already described the risk of nosocomial acquisition, alerting infection control services around the world [1] . To face this threat, since the beginning of this pandemic, society and government-sponsored guidance on infection prevention and control (IPC) for health care institutions was developed, tailored by countries and by institutions according to their specific conditions and updated as the evidence advanced [2,3,4]. Backbones of IPC in all healthcare facilities are the appropriate use of personal protective equipment (PPE), isolation of suspected and confirmed COVID-19 cases, provision of adequate infra-structure and administrative measures, environmental cleaning and ventilation, physical distancing; and hand hygiene.

The risk of acquiring COVID-19 during hospitalization was recently evaluated in a report including 314 United Kingdom hospitals. Authors estimated that 7% of all COVID-19 patients had acquired the infection in the hospital [5] . Although the risk of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission within hospitals has been well recognized, there is a paucity of data on its occurrence, especially at the national level. Our aim was to report the incidence of hospital-acquired (HA) COVID-19 at Brazilian hospitals.

J o u r n a l P r e -p r o o f

We investigated the incidence of HA COVID-19 in Brazilian hospitals using data collected through a national surveillance system, from August 2020 through September 2021.

Brazil has 27 states, approximately 6,425 hospitals, of which approximately 2,000 have intensive care units (ICUs). Since 2010, there is a nationwide surveillance system to monitor healthcare-associated infections in hospitals, coordinated by the federal government through the Brazilian Health Regulatory Agency (ANVISA). Starting in August 2020, hospitals were instructed to monthly report data on the occurrence HA COVID-19, reporting was nonmandatory. Surveillance definitions for HA COVID-19 were: symptom onset >14 after admission, and positive SARS-CoV-2 RNA or rapid antigen test antigen positive; OR symptom onset on days 8-14 after admission, and SARS-CoV-2 RNA or rapid antigen test antigen positive and epidemiologically link to the high-risk exposure within the hospital such as with a health care worker (HCW), another patient, or visitors. For neonatal units, additional criteria were: hospitalized since birth and SARS-CoV-2 RNA or rapid antigen test antigen positive collected after 48 hours of life [6] .

Data were notified using the electronic form Limesurvey, available on the ANVISA website (https://pesquisa.ANVISA.gov.br/index.php/667695?lang=pt-BR). Data were reported separately by type of ICU (adult, pediatric, and neonatal), and medical or surgical units. We evaluated data from August 2020 through September 2021.

Data on COVID-19 in the community were obtained through the official website of Brazil´s Ministry of Health [7].

We performed descriptive analyses and calculated two rates: proportion of patients with HA COVID-19 (dividing the number of HA COVID-19 by the number of hospital-discharged patients and multiplying the result by 100). Incidence of HA COVID-19 (dividing the number of HA COVID-19 by the number of patient-days and multiplying the result by 1,000; similar to other healthcare-associated infections). We calculated the pooled mean and percentile distribution of incidence. Duplicate notifications were excluded and we maintained the most recent notification.

J o u r n a l P r e -p r o o f

During the study period 48,634 cases of HA COVID-19 were reported from 1,428 hospitals, with a peak in March 2021, when 8,929 cases were reported. Among the hospitals, 35% were public, 31% non-profit, and 30% private. Adult ICUs and adults medical-surgical units presented higher rates of HA COVID-19 than pediatric and neonatal ICUs ( Table 1 ).

The highest incidence of HA COVID-19 was during the months March to July 2021, similar of what was observed of community-acquired COVID-19 (Figure 1 ).

To the best of our knowledge, this is the first report evaluating nosocomial transmission of SARS-CoV-2 based on a national surveillance system. Published articles usually describe the proportion among COVID-19 cases that were nosocomial acquired [5, 8] . Since the beginning of this pandemic ANVISA has played a pivotal role guiding by strategies for infection prevention and control of COVID-19 for hospitals and other healthcare settings [9] . In August 2020, as part of the COVID-19 Strategic Preparedness and Response Plan, ANVISA developed the HA COVID-19 surveillance system, expecting to produce essential data that is reported here. In this sense, it was remarkable to detect almost 50,000 cases of HA COVID-19 during the study period, re-iterating the importance of creating a system that allowed measuring the burden of hospital-acquired cases. Besides collecting statistics, we believe that the implementation of a national system to evaluate HA COVID-19 has the potential to uncover this challenge and develop interventions in each hospital. In other words, we believe that the requirement to report rates may have influenced institutions to either adopt or review their infection control strategies.

The highest incidence of HA COVID-19 was among adult ICUs and medical-surgical units during the months March to July 2021, similar of what was observed with community-acquired COVID-19. Adequate control measures should have prevented the influence of the incidence of COVID-19 in the community cases over hospital-acquired cases. We speculate that this behavior reflects the difficulty of implementing effective prevention measures during periods of high transmission. In this scenario of high transmission in the community, hospitals experienced several challenges, such as a shortage of trained professionals, both due to excess work and absences due to COVID-19, leading to high turnover of HCW and the presence of professionals with less experience in ICU care and perhaps in preventative measures.

Although the adherence rate indicates underreporting, we think there were a suitable number of hospitals reporting this indicator. Moreover, considering only hospitals with ICUs (that were probably the ones responsible for assisting severe COVID-19 cases), the adherence rate was 60%, which we considered, a representative sample. We attribute this readiness to report data, to the already existing structure, beliefs, trust, and habit of infection control services in surveillance systems sponsored by the government.

Our study has limitations. First, the adherence rate indicates underreporting, either because the hospital decided not to notify its data, or due to limited access to laboratory tests. However, we believe that our sample of more than 1,000 hospitals is valuable. Furthermore, as already discussed, a great proportion of Brazilian hospitals are small (less than 50 beds) and primary-level hospitals (without specialized care and limited laboratory services). These small health institutions did not provide care to COVID-19 patients and thus did not report data. Secondly, it was not possible to make a detailed characterization of patients affected by HA COVID-19 and to link the risk with infection control strategies. We are aware that it would be helpful to have descriptive data of adherence of hospitals to recommendations and to provide analysis of institution and national risk factors. However, we believe that the data from our surveillance system was a first step and brought useful information on the burden of HA COVID-19. Further studies are needed to address these points. Unfortunately, it was not J o u r n a l P r e -p r o o f possible to compare the incidences between different types of hospitals (i.e, privates versus public, academic versus general, and hospital size) and with infection control strategies. Third, with the definition, we adopted (> 14 days after admission as HA), cases may have been missed. Finally, clinical data of HA COVID-19 cases were unavailable.

In conclusion, this report provides a national view of the burden of HA COVID-19. Data from 1,428 Brazilian hospitals showed 48,634 cases of HA COVID-19 reported during 13 months, and an incidence of HA COVID-19 that varied widely and was much higher in adult ICUs (0.16 per

):1113. 2 -Infection prevention and control during health care when coronavirus disease (COVID-19) is suspected or confirmed

Guidance on infection prevention and control for seasonal respiratory infections including SARS-CoV-2. UK Health Security Agency

Infection Prevention and Control Recommendations for Healthcare Personnel During the Coronavirus Disease 2019 (COVID-19) Pandemic. Updated Sept

Hospital-acquired SARS-CoV-2 infection in the UK's first COVID-19-19 pandemic wave

Guidelines for the Prevention and Epidemiological Surveillance of SARS-CoV-2 Infections

Hospital-Acquired SARS-Cov-2 Infections in Patients: Inevitable Conditions or Medical Malpractice?

Guidelines for healthcare services: measures of prevention and control that should be adopted during case assistance suspected or confirmed of infection by new coronavirus (SARS-CoV-2)